Yousef Salama
Overview
Explore the profile of Yousef Salama including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
243
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ayoup M, Daqa M, Salama Y, Hazzam R, Hawsawi M, Soliman S, et al.
Molecules
. 2025 Feb;
30(4).
PMID: 40005107
The synthesis of 7--carboxymethyl-4'-fluoroisoflavone and 7--carboxymethyl-4'-fluoro-2-trifluormethylisoflavone involved the cyclization of 2,4-dihydroxy-4'-fluorodeoxybenzoin , followed by 7--alkylation with methyl bromoacetate and subsequent acid-catalyzed hydrolysis. The structures of the novel compounds were validated...
2.
Al-Qadi I, Hanania M, Warad I, Al-Hajj N, Hazzam R, Salama Y, et al.
BMC Chem
. 2025 Feb;
19(1):48.
PMID: 39987147
Despite their importance in cancer treatment, anticancer compounds face significant challenges due to drug resistance and low specificity, creating an urgent need for the discovery of more effective alternative. Herein,...
3.
Salama Y, Munakata S, Osada T, Takahashi S, Hattori K, Heissig B
Cell Death Dis
. 2024 Oct;
15(10):753.
PMID: 39419989
MicroRNAs, including the tumor-suppressor miR-126 and the oncogene miR-221, regulate tumor formation and growth in colitis-associated cancer (CAC) and colorectal cancer (CRC). This study explores the impact of the epithelial...
4.
Yatsenko T, Rios R, Nogueira T, Salama Y, Takahashi S, Adachi E, et al.
Front Immunol
. 2024 Sep;
15:1445294.
PMID: 39281671
Introduction: Plasminogen activator inhibitor-1 (PAI-1) is linked to thrombosis and endothelial dysfunction in severe COVID-19. The +43 G>A PAI-1 and 4G/5G promoter polymorphism can influence PAI-1 expression. The 4G5G PAI-1...
5.
Skrypnyk M, Yatsenko T, Riabets O, Salama Y, Skikevych M, Osada T, et al.
Heliyon
. 2024 Jun;
10(11):e31777.
PMID: 38882335
Treatment resistance after chemo-/immunotherapy occurs in patients with head and neck squamous cell cancers (HNSCs), including salivary gland cancers (SGCs). Interleukin-10 (IL-10), a cytokine with pro- and anti-cancer effects, has...
6.
Yatsenko T, Rios R, Nogueira T, Salama Y, Takahashi S, Tabe Y, et al.
Front Immunol
. 2024 Mar;
15:1390698.
PMID: 38545120
[This corrects the article DOI: 10.3389/fimmu.2023.1299792.].
7.
Al-Maharik N, Salama Y, Al-Hajj N, Jaradat N, Jobran N, Warad I, et al.
BMC Complement Med Ther
. 2024 Feb;
24(1):94.
PMID: 38365676
The primary aim of this investigation was to determine the anticancer and antimicrobial properties of essential oils (EOs) extracted from the leaves of Aloysia citriodora Palau, which were procured from...
8.
Salama Y, Takahashi S, Tsuda Y, Okada Y, Hattori K, Heissig B
Cancers (Basel)
. 2023 Jan;
15(1).
PMID: 36612285
The multifunctional endocytic receptor low-density lipoprotein receptor-related protein 1 (LRP1) has been implicated in melanoma growth. However, the mechanism of LRP1 expression in melanoma cells remains only partially understood. In...
9.
Heissig B, Salama Y, Iakoubov R, Vehreschild J, Rios R, Nogueira T, et al.
Biomedicines
. 2022 Oct;
10(10).
PMID: 36289811
Although there is strong evidence that SARS-CoV-2 infection is associated with adverse outcomes in certain ethnic groups, the association of disease severity and risk factors such as comorbidities and biomarkers...
10.
Heissig B, Salama Y, Tateno M, Takahashi S, Hattori K
EJHaem
. 2022 Sep;
3(3):849-861.
PMID: 36051085
Acute graft-versus-host disease (aGvHD) remains a major threat to a successful outcome after allogeneic hematopoietic stem cell transplantation (HSCT). Although antibody-based targeting of the CD40/CD40 ligand costimulatory pathway can prevent...